Merck & Co. Selects STACS™ Casework to Help Combat Pharmaceutical Drug Counterfeiting
Share Article OTTAWA (PRWEB) March 10, 2021 STACS DNA, the sample tracking solutions company, announced today that Merck (known as MSD outside of the U.S. and Canada) has selected STACS Casework sample tracking and lab management software to be used by their three forensic laboratories to support the identification and detection of counterfeit products. Merck is a premier research-intensive biopharmaceutical company that develops medicines and vaccines for many of the world’s most challenging diseases.
The goal of Merck’s ISO-accredited forensic laboratories, located in the United States, Switzerland and Singapore, is to protect citizens worldwide against the threat of counterfeit pharmaceutical drugs. STACS Casework will provide end-to-end sample tracking, quality controls and chain of custody while streamlining tasks for